express scripts glp 1 coverage change expands Patient Assurance Program to drive affordability and access to GLP-1s Frequently Asked Questions | Express

Is Rybelsus a GLP-1 receptor agonist

Though both payers had similar approval rates for anti-obesity GLP-1s in Medicare by Q2-2025, the paths to that point were unique to each payer

Part of this notice of change for prior authorizations appears to streamline the process and make it more transparent, part of it increases burden of proof to Rx

Nearly half of GLP-1 patients now start therapy within a month of diabetes diagnosis

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field

Learn how AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide work